Health Care up on Rotation Out of AI - Health Care Roundup

Dow Jones07-03 05:05

Health-care companies rose as traders continued to rotate out of high-risk artificial-intelligence stocks into lagging sectors.

Shares of Moderna added to recent gains amid optimism the vaccine maker's efforts to diversify its offerings would bear fruit.

Roche Holding said a drug candidate showed better potential than existing therapies in a late-stage study with patients with a type of advanced lung cancer who had been previously treated.

Abivax shares added to recent gains after the French biotechnology company increased the size of a stock offering, signaling investor appetite in the wake of positive clinical-trial data.

Recent Abivax data on an ulcerative colitis product candidate showed promise, said analysts at brokerage Stifel.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

July 02, 2026 17:05 ET (21:05 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2648636635?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 05:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648636635","market":"other","top_or_hot":-1,"title":"Health Care up on Rotation Out of AI - Health Care Roundup","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health-care companies rose as traders continued to rotate out of high-risk artificial-intelligence stocks into lagging sectors. \n</p>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> added to recent gains amid optimism the vaccine maker's efforts to diversify its offerings would bear fruit. \n</p>\n<p>\n  Roche Holding said a drug candidate showed better potential than existing therapies in a late-stage study with patients with a type of advanced lung cancer who had been previously treated. \n</p>\n<p>\n  Abivax shares added to recent gains after the French biotechnology company increased the size of a stock offering, signaling investor appetite in the wake of positive clinical-trial data. \n</p>\n<p>\n  Recent Abivax data on an ulcerative colitis product candidate showed promise, said analysts at brokerage <a href=\"https://laohu8.com/S/SFB\">Stifel</a>. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 02, 2026 17:05 ET (21:05 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Health Care up on Rotation Out of AI - Health Care Roundup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealth Care up on Rotation Out of AI - Health Care Roundup\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-03 05:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health-care companies rose as traders continued to rotate out of high-risk artificial-intelligence stocks into lagging sectors. \n</p>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> added to recent gains amid optimism the vaccine maker's efforts to diversify its offerings would bear fruit. \n</p>\n<p>\n  Roche Holding said a drug candidate showed better potential than existing therapies in a late-stage study with patients with a type of advanced lung cancer who had been previously treated. \n</p>\n<p>\n  Abivax shares added to recent gains after the French biotechnology company increased the size of a stock offering, signaling investor appetite in the wake of positive clinical-trial data. \n</p>\n<p>\n  Recent Abivax data on an ulcerative colitis product candidate showed promise, said analysts at brokerage <a href=\"https://laohu8.com/S/SFB\">Stifel</a>. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 02, 2026 17:05 ET (21:05 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XBI","symbol_name":"SPDR S&P Biotech ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2648636635","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2648636635","pubTimestamp":1783026300,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Health-care companies rose as traders continued to rotate out of high-risk artificial-intelligence stocks into lagging sectors.Shares of Moderna added to recent gains amid optimism the vaccine maker's efforts to diversify its offerings would bear fruit.Roche Holding said a drug candidate showed better potential than existing therapies in a late-stage study with patients with a type of advanced lung cancer who had been previously treated.Abivax shares added to recent gains after the French biotechnology company increased the size of a stock offering, signaling investor appetite in the wake of positive clinical-trial data.Recent Abivax data on an ulcerative colitis product candidate showed promise, said analysts at brokerage Stifel.Write to Rob Curran at rob.curran@dowjones.com Dow Jones NewswiresJuly 02, 2026 17:05 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XBI":"SPDR S&P Biotech ETF","BK4588":"碎股","AIPO":"Defiance AI and Power Infrastructure ETF","BK4585":"ETF&股票定投概念","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","LABU":"三倍做多标普生物-Direxion","BK4581":"高盛持仓","AGIX":"通用人工智能 ETF-AGIX","XLV":"健康照护类股ETF-SPDR","ARTY":"ISHARES FUTURE AI & TECH ETF"},"translate_title":"医疗保健在人工智能之外轮换-医疗保健综述","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGIX":1.5,"AIPO":1.5,"ARTY":1.5,"XBI":0.6,"XLV":1.5,"LABU":0.6,"CHAT":1.5},"content_text":"Health-care companies rose as traders continued to rotate out of high-risk artificial-intelligence stocks into lagging sectors. \n\n\n  Shares of Moderna added to recent gains amid optimism the vaccine maker's efforts to diversify its offerings would bear fruit. \n\n\n  Roche Holding said a drug candidate showed better potential than existing therapies in a late-stage study with patients with a type of advanced lung cancer who had been previously treated. \n\n\n  Abivax shares added to recent gains after the French biotechnology company increased the size of a stock offering, signaling investor appetite in the wake of positive clinical-trial data. \n\n\n  Recent Abivax data on an ulcerative colitis product candidate showed promise, said analysts at brokerage Stifel. \n\n\n \n\n\n  Write to Rob Curran at rob.curran@dowjones.com \n\n\n  (END) Dow Jones Newswires\n\n\n  July 02, 2026 17:05 ET (21:05 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2648636635","isCrawlerRequest":true}